Give me a notes about Gastrointestinal disorders: GERD, APD, Malabsorption Syndrome
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive content from authoritative sources. Let me compile the complete notes.
Gastrointestinal Disorders: GERD, APD, and Malabsorption Syndrome
1. Gastroesophageal Reflux Disease (GERD)
Definition
GERD is a chronic disorder characterized by heartburn that occurs when gastric acid or bile refluxes from the stomach into the esophagus, inducing inflammation of the esophageal mucosa. It may progress to erosive esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
(Yamada's Textbook of Gastroenterology)
Pathophysiology
The core mechanism involves impairment of the anti-reflux barrier at the gastroesophageal junction:
| Mechanism | Effect |
|---|---|
| ↓ Lower Esophageal Sphincter (LES) pressure | Allows gastric contents to reflux into esophagus |
| ↓ Intraabdominal LES length | Reduces competence of the sphincter |
| Esophageal motor dysfunction | Impairs acid clearance |
| ↑ Intraabdominal pressure (e.g., obesity) | Forces contents upward |
- Obesity is a major contributing factor: abdominal obesity (waist >88 cm in women, >102 cm in men) increases intraabdominal pressure, reduces LES pressure, increases acid production, and promotes esophageal motor dysfunction.
- Obesity carries an OR = 2.15 (95% CI 1.89–2.45) for GERD development.
- Association is stronger in women (attributed to higher estrogen levels) and in Caucasians. (Yamada's Textbook of Gastroenterology)
Clinical Features
- Typical symptoms: Heartburn (pyrosis), regurgitation, waterbrash
- Atypical/extraesophageal symptoms:
- Chronic cough, hoarseness, laryngitis
- Dental enamel erosion (palatal surfaces of maxillary teeth, sensitivity to temperature, irreversible)
- Asthma exacerbations
- Non-cardiac chest pain
Complications
| Complication | Risk (OR/RR) |
|---|---|
| Erosive esophagitis | OR = 1.87 (1.51–2.31) with obesity |
| Barrett's esophagus | OR = 4.0 (1.4–11.1) with obesity |
| Esophageal adenocarcinoma | Men OR = 2.4; Women OR = 2.1; RR up to 4.8 |
(Yamada's Textbook of Gastroenterology)
Diagnosis
- Clinical diagnosis based on typical symptoms; empiric PPI trial
- Upper endoscopy (EGD): for alarm symptoms (dysphagia, odynophagia, weight loss, bleeding), suspected Barrett's or malignancy
- 24-hour pH monitoring / MII-pH: gold standard to confirm acid exposure, performed on or off PPI therapy
- Manometry: to assess LES pressure and esophageal motility
Treatment
Lifestyle modifications:
- Weight loss (proven to reduce GERD in intervention trials)
- Avoid trigger foods (fatty meals, citrus, coffee, alcohol, spicy foods)
- Small frequent meals; avoid nighttime meals
- Elevate head of bed
Pharmacologic:
| Drug Class | Role |
|---|---|
| Proton Pump Inhibitors (PPIs) | Cornerstone of treatment (e.g., omeprazole, pantoprazole) |
| H₂-Receptor Antagonists | Useful for mild-moderate symptoms; also for dental erosion (enamel protection) |
| Antacids | Short-term symptom relief |
Surgical: Laparoscopic Nissen fundoplication — for refractory GERD or when patients prefer surgical management
(Goldman-Cecil Medicine; Schwartz's Principles of Surgery)
2. Acid Peptic Disease (APD) / Peptic Ulcer Disease (PUD)
Definition
APD encompasses conditions arising from an imbalance between mucosal protective factors and damaging factors, including peptic ulcer disease (gastric and duodenal ulcers), erosive gastritis, and Zollinger-Ellison syndrome.
Pathophysiology
Protective Factors (mucosal defense):
- Mucus-bicarbonate (HCO₃⁻) barrier — traps HCO₃⁻ and neutralizes H⁺ before it reaches epithelial cells
- Prostaglandin E₂ — maintains barrier integrity and stimulates HCO₃⁻ secretion
- Mucosal blood flow
- Growth factors
Damaging Factors:
- H⁺ and pepsin (pepsinogen activated at low pH → pepsin digests mucosa)
- Helicobacter pylori infection
- NSAIDs / aspirin (suppress prostaglandin synthesis → ↓ mucosal protection)
- Stress, smoking, alcohol
- High-dose corticosteroids
Peptic ulcer disease results from an imbalance between protective and damaging forces. For an ulcer to form, there must be: (1) loss of the mucous barrier, (2) excessive H⁺/pepsin secretion, or (3) both. (Costanzo Physiology, 7th Ed.)
Epidemiology
- More than 4 million individuals in the United States are treated for PUD annually
- Lifetime risk: ~10% in males, ~4% in females
-
70% of PUD cases are associated with H. pylori infection
- Only 5–10% of H. pylori-infected individuals develop ulcers (host factors and strain variation matter)
- NSAID use is becoming the most common cause of gastric ulcers as H. pylori rates fall (Robbins & Kumar Basic Pathology)
Types of Peptic Ulcers
Gastric Ulcers:
- Primarily due to defective mucosal barrier
- H. pylori colonizes gastric antrum → releases cytotoxins (CagA toxin) → breaks down mucus and epithelial cells
- H. pylori survives by producing urease → converts urea to NH₃ → alkalinizes local environment
- Net H⁺ secretion is paradoxically lower than normal in gastric ulcers (H⁺ leaks into damaged mucosa)
- Gastrin secretion is increased (because H⁺ inhibition of gastrin is lost)
Duodenal Ulcers:
- More common than gastric ulcers
- Primarily due to excessive H⁺ secretion
- Excess H⁺ delivered to duodenum overwhelms HCO₃⁻ buffering → ulceration
- Baseline gastrin may be normal but meal-stimulated gastrin is increased
- Parietal cell mass is increased (trophic effect of elevated gastrin)
Zollinger-Ellison Syndrome:
- Pancreatic islet cell tumor (gastrinoma) secretes gastrin constitutively
- Massive acid production → ulcers in stomach, duodenum, even jejunum
- Excess H⁺ in duodenum inactivates pancreatic lipases → steatorrhea
- Treatment: high-dose PPIs (e.g., cimetidine, omeprazole) + surgical tumor resection (Costanzo Physiology, 7th Ed.)
Risk/Contributing Factors
- Alcohol-related cirrhosis
- COPD
- Chronic renal failure
- Hyperparathyroidism (hypercalcemia → ↑ gastrin → ↑ acid) (Robbins & Kumar Basic Pathology)
Diagnosis (H. pylori)
- ¹³C-Urea Breath Test: Patient ingests ¹³C-urea → urease converts it to ¹³CO₂ + NH₃ → ¹³CO₂ measured in expired breath (non-invasive, highly accurate)
- Stool antigen test
- Endoscopy + biopsy: CLO test (urease activity), histology, culture
- Serology: detects IgG antibodies (not useful for active infection)
Treatment
H. pylori Eradication (Triple Therapy):
- PPI + Clarithromycin + Amoxicillin (or Metronidazole) × 14 days
Acid Suppression:
| Class | Examples |
|---|---|
| PPIs | Omeprazole, Pantoprazole, Lansoprazole |
| H₂ Blockers | Ranitidine, Famotidine |
NSAID-induced ulcers:
- Discontinue NSAID + PPI therapy
- Consider misoprostol (prostaglandin analog) for prophylaxis in high-risk patients
Surgical (complications):
- Bleeding: oversewing of vessel or partial gastrectomy
- Perforation: patch closure (Graham patch)
- Obstruction: drainage procedure (Schwartz's Principles of Surgery, 11th Ed.; Sabiston Textbook of Surgery)
3. Malabsorption Syndrome
Definition
Malabsorption syndrome is a clinical pattern of nutrient deficiency arising from impaired digestion and/or absorption in the small intestine. It encompasses deficient absorption of amino acids, carbohydrates, fats, fat-soluble vitamins, minerals, and other nutrients.
Pathophysiology
The small intestine has an anatomic reserve — removal of short segments usually does not cause severe malabsorption. However:
- Resection of >50% of small intestine (short gut syndrome) → severe malnutrition
- Resection of terminal ileum → impaired bile acid reabsorption → deficient fat absorption + secretory diarrhea (bile acids activate Cl⁻ secretion in colon)
Fat Malabsorption and Steatorrhea:
- Absorbed fatty acids with >10–12 carbon atoms cannot dissolve freely → re-esterified to triglycerides in enterocytes
- Packaged into chylomicrons (coated with protein, cholesterol, phospholipid) → leave via exocytosis → enter lymphatics (too large for portal veins)
- Disruption of this pathway → steatorrhea (fat in stool)
(Ganong's Review of Medical Physiology, 26th Ed.)
Causes
Mucosal Diseases:
- Celiac disease (autoimmune; gluten-triggered)
- Eosinophilic gastroenteritis
- HIV enteropathy
- Autoimmune enteropathy
- Intestinal lymphoma
Infections:
- Giardia lamblia, Cryptosporidium parvum, Cyclospora, Cystoisospora
- Mycobacterium tuberculosis, M. avium intracellulare
- Strongyloides stercoralis, Capillaria philippinensis
- Fungi: Enterocytozoon bieneusi (microsporidiosis)
Pancreatic Insufficiency:
- Chronic alcoholic pancreatitis
- Cystic fibrosis (CF)
- Tropical pancreatitis
Lymphatic Obstruction:
- Intestinal lymphangiectasia
(Sleisenger & Fordtran's GI and Liver Disease)
Celiac Disease (Prototype Cause)
- Autoimmune disorder in genetically predisposed individuals
- Trigger: gluten and related proteins in wheat, rye, barley (not rice or corn)
- Intestinal T cells mount an inappropriate immune response → damage to intestinal epithelial cells → loss of villi, mucosal flattening
- Result: dramatic reduction in absorptive surface area
Treatment: Strict gluten-free diet → mucosa returns to normal
(Ganong's Review of Medical Physiology, 26th Ed.)
Clinical Features (Pattern of Deficiencies)
| Deficiency | Manifestation |
|---|---|
| Fat malabsorption | Steatorrhea (bulky, greasy, foul-smelling stools), weight loss |
| Fat-soluble vitamins (A, D, E, K) | Night blindness (Vit A); Osteomalacia/Rickets (Vit D); Coagulopathy (Vit K); Neuropathy (Vit E) |
| Protein/amino acids | Body wasting, hypoproteinemia, edema |
| Carbohydrates | Osmotic diarrhea, bloating, flatulence |
| Calcium | Hypocalcemia → tetany, osteopenia; arthritis |
| Iron/Folate/B₁₂ | Anemia (microcytic, megaloblastic) |
| Bile acid malabsorption | Secretory diarrhea, ↓ fat digestion |
Other complications of intestinal resection: hypocalcemia, arthritis, fatty liver → cirrhosis
Diagnosis
- Stool fat test (Sudan stain / 72-hr fecal fat): confirms steatorrhea
- Anti-tTG IgA / anti-endomysial antibodies: celiac disease
- Duodenal biopsy: villous atrophy (celiac), pathogens, lymphangiectasia
- D-xylose absorption test: mucosal function (abnormal in mucosal disease, normal in pancreatic insufficiency)
- Breath tests: lactose/fructose intolerance, SIBO (small intestinal bacterial overgrowth)
- Fecal elastase: pancreatic exocrine insufficiency
Treatment
| Cause | Treatment |
|---|---|
| Celiac disease | Strict gluten-free diet |
| Bile acid malabsorption | Cholestyramine (bile acid sequestrant) |
| Pancreatic insufficiency | Pancreatic enzyme replacement |
| Fat-soluble vitamin deficiency | Water-soluble derivatives of vitamins A, D, E, K |
| Severe short bowel syndrome | Total parenteral nutrition (TPN) |
| End-stage | Small bowel transplantation (long-term complications; requires donor tissue) |
(Ganong's Review of Medical Physiology; Sleisenger & Fordtran's; Harrison's Principles of Internal Medicine 22E)
Quick Comparison Summary
| Feature | GERD | APD/PUD | Malabsorption |
|---|---|---|---|
| Primary site | Esophagus | Stomach / Duodenum | Small intestine |
| Key mechanism | ↓ LES pressure → reflux | ↑ Acid / ↓ mucosal defense | ↓ Absorption of nutrients |
| Major cause | Obesity, LES dysfunction | H. pylori, NSAIDs | Celiac disease, pancreatic insufficiency, infections |
| Classic symptom | Heartburn, regurgitation | Epigastric pain, hunger pain | Steatorrhea, weight loss, diarrhea |
| Key diagnostic test | 24-hr pH monitoring | ¹³C-urea breath test / EGD | Fecal fat, duodenal biopsy |
| Cornerstone treatment | PPI + lifestyle changes | H. pylori eradication + PPI | Treat underlying cause |
Sources: Costanzo Physiology 7th Ed. · Robbins & Kumar Basic Pathology · Ganong's Review of Medical Physiology 26th Ed. · Yamada's Textbook of Gastroenterology 7th Ed. · Sleisenger & Fordtran's GI and Liver Disease · Goldman-Cecil Medicine · Schwartz's Principles of Surgery 11th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.